Rocket Pharmaceuticals earnings were -$17.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest RCKT earnings report on Jun 30, 2026 announced Q2 2026 earnings of $123.2M, down 358.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, RCKT reported annual earnings of -$223.1M, with -13.8% growth. The next RCKT earnings date is Nov 5, 2026.
Rocket Pharmaceuticals Earnings Reports & History FAQ
What were Rocket Pharmaceuticals's earnings last quarter?
On RCKT's earnings call on Aug 6, 2026, Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q2 2026 earnings per share (EPS) of $1.09, up 275.81% year over year. Total RCKT earnings for the quarter were $123.21 million. In the same quarter last year, Rocket Pharmaceuticals's earnings per share (EPS) was -$0.62.
The next RCKT earnings date is Nov 5, 2026. Add RCKT to your watchlist to be reminded of Rocket Pharmaceuticals's next earnings date.
Is Rocket Pharmaceuticals profitable or losing money?
As of the last Rocket Pharmaceuticals earnings report, Rocket Pharmaceuticals is currently losing money. Rocket Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$17.25 million, a 93.3% decrease year over year.
What was RCKT's earnings growth in the past year?
As of Rocket Pharmaceuticals's earnings date in Aug 6, 2026, Rocket Pharmaceuticals's earnings has grown year over year. RCKT earnings in the past year totalled -$17.25 million.
What are Rocket Pharmaceuticals's earnings expectations?
The current EPS estimate for Rocket Pharmaceuticals's earnings report in Nov 5, 2026 is -$0.38.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.